• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Friday 12/14/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

DCTH

  • 3:44 PM

    NEW YORK, Feb. 10, 2016, DCTH, /PRNewswire/ — Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces that patient enrollment has begun in the Company’s Phase 3 clinical trial:  “A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular Melanoma” (the FOCUS Trial). The first patient was evaluated and randomized into

    Read more
  • 2:18 PM

    LOS ANGELES, July 1, 2014 /PRNewswire/ — Medbox, Inc. (OTCQB: MDBX) (www.medbox.com), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, today announced that the company’s Form 10 filing has been deemed effective by the Securities and Exchange Commission, with no outstanding comments left to address. Dr. Bruce Bedrick, CEO of Medbox, commented, “This step is another milestone for our Company as we continue to build market leadership in the cannabis industry.  We believe that compliance and transparency are

    Read more
  • 12:36 PM

    “Xtreme is excited to be taking this critical step for our shareholders. Our expanding asset base and continued oil and gas production leave us well positioned for continued growth in the future.”

    Read more
Public Wire Banner